Related Experiment Video
Updated: Aug 11, 2026
11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
The modified Makari skin test in urology--is it significant?
British Journal of Urology
|January 1, 1977
Summary
The Makari test detects cancer in 95% of primary tumor patients. This cancer detection method is useful for monitoring treatment, though further study is needed for unexplained positive results.
Area of Science:
- Oncology
- Immunology
Background:
- Early cancer detection remains a significant challenge in oncology.
- Monitoring treatment efficacy requires reliable diagnostic tools.
Purpose of the Study:
- To evaluate the diagnostic accuracy of the Makari test for primary tumors.
- To assess the utility of the Makari test in monitoring cancer treatment.
- To investigate unexplained positive test results in a control group.
Main Methods:
- The Makari test was administered to patients with primary tumors, excluding anergic individuals.
- Test performance was assessed for cancer detection.
- The test's utility in monitoring treatment was evaluated.
- A control group with unexplained positive reactions was monitored long-term.
Main Results:
- The Makari test demonstrated a 95% detection rate in patients with primary tumors.
- The test showed utility in monitoring primary treatment effectiveness.
- Unexplained positive reactions were observed in a control group, necessitating further investigation.
Conclusions:
- The Makari test is a highly sensitive diagnostic tool for primary cancer detection.
- The Makari test can aid in monitoring patient treatment response.
- Further long-term follow-up is required to understand the etiology of false-positive Makari test results in specific patient cohorts.
